[CLINICAL EXPERINCES WITH A NEW ANTIINFLAMMATORY-ANTIRHEUMATIC DRUG].
D000632:Aminopyrine; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D018501:Antirheumatic Agents; D001168:Arthritis; D001172:Arthritis, Rheumatoid; D035843:Biomedical Research; D001996:Bronchopneumonia; D002701:Chloramphenicol; D002751:Chlortetracycline; D006689:Hodgkin Disease; D006801:Humans; D007251:Influenza, Human; D010406:Penicillins; D010600:Pharmacology; D010998:Pleurisy; D011014:Pneumonia; D013307:Streptomycin
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D058633:Antipyretics; D018501:Antirheumatic Agents; D010406:Penicillins; D000632:Aminopyrine; D002701:Chloramphenicol; D002751:Chlortetracycline; D013307:Streptomycin
AMINOPYRINE; ANALGESICS AND ANTIPYRETICS; ARTHRITIS, RHEUMATOID; BRONCHOPNEUMONIA; CHLORAMPHENICOL; CHLORTETRACYCLINE; CLINICAL RESEARCH; HODGKIN'S DISEASE; INFLUENZA; PENICILLIN; PHARMACOLOGY; PLEURISY; PNEUMONIA; STREPTOMYCIN
ESPERIENZE CLINICHE CON UN NUOVO FARMACO ANTIFLOGISTICO-ANTIREUMATICO.